- Home
- CVCO vs SLNO Comparison
CVCO vs SLNO Comparison
Compare CVCO & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVCO
- SLNO
- Stock Information
- Founded
- CVCO 1965
- SLNO 1999
- Country
- CVCO United States
- SLNO United States
- Employees
- CVCO N/A
- SLNO N/A
- Industry
- CVCO Homebuilding
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CVCO Consumer Discretionary
- SLNO Health Care
- Exchange
- CVCO Nasdaq
- SLNO Nasdaq
- Market Cap
- CVCO 4.3B
- SLNO 3.8B
- IPO Year
- CVCO N/A
- SLNO 2014
- Fundamental
- Price
- CVCO $417.47
- SLNO $86.47
- Analyst Decision
- CVCO Buy
- SLNO Strong Buy
- Analyst Count
- CVCO 2
- SLNO 9
- Target Price
- CVCO $522.50
- SLNO $105.11
- AVG Volume (30 Days)
- CVCO 160.3K
- SLNO 1.5M
- Earning Date
- CVCO 08-04-2025
- SLNO 08-06-2025
- Dividend Yield
- CVCO N/A
- SLNO N/A
- EPS Growth
- CVCO 12.74
- SLNO N/A
- EPS
- CVCO 20.71
- SLNO N/A
- Revenue
- CVCO $2,015,458,000.00
- SLNO N/A
- Revenue This Year
- CVCO $8.56
- SLNO N/A
- Revenue Next Year
- CVCO $6.08
- SLNO N/A
- P/E Ratio
- CVCO $20.16
- SLNO N/A
- Revenue Growth
- CVCO 12.29
- SLNO N/A
- 52 Week Low
- CVCO $351.28
- SLNO $41.50
- 52 Week High
- CVCO $549.99
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- CVCO 41.58
- SLNO 56.32
- Support Level
- CVCO $406.75
- SLNO $85.76
- Resistance Level
- CVCO $432.78
- SLNO $89.12
- Average True Range (ATR)
- CVCO 12.46
- SLNO 3.14
- MACD
- CVCO -2.12
- SLNO -0.06
- Stochastic Oscillator
- CVCO 21.46
- SLNO 63.75
About CVCO Cavco Industries Inc. When Issued
Cavco Industries Inc designs and produces factory-built homes under the Cavco Homes, Fleetwood Homes, and Palm Harbor Homes brands. It also produces modular homes, park model homes, and vacation cabins, as well as commercial structures, among others. The company operates principally in two segments: Factory-built housing, which includes wholesale and retail systems-built housing operations, and the Financial services segment, which includes manufactured housing consumer finance and insurance. Cavco receives a majority of its revenue from the Factory-built housing segment.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.